ArticleFrontiers in cardiovascular medicine2026

Early escalation of oral lipid-lowering therapy to achieve LDL-cholesterol targets in patients after myocardial infarction: study protocol for the prospective, open-label HAnnover ChOlesterol Lowering in Acute Coronary Syndrome trial.

Andreas Schäfer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.